A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma (in Chinese).
The results of the autologous peripheral blood stem cells collection, toxicity, engraftment after ICE-based mobilization regimen were analyzed in this study.
Kanthan, "Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell
transplantation for refractory germ cell tumor," Bone Marrow Transplantation, vol.
The newest adult stem cell collection center in the NeoStem network, located at the Giampapa Institute for Anti-Aging Medical Therapy (Montclair, NJ), has received, from the state of New Jersey Department of Health and Senior Services, a blood bank license for autologous peripheral blood stem cell
Conclusion: Single low-dose pegfilgrastim as part of a mobilization strategy for autologous peripheral blood stem cell
transplant is a viable alternative to filgrastim.
Multiple myeloma had been diagnosed in 1997, and the patient had been treated with multiple cycles of antiproliferative chemotherapy and had received autologous peripheral blood stem cell
Autologous peripheral blood stem cell transplantation (APBSCT) has dramatically increased worldwide involving peripheral blood stem cells as a source of hematopoietic stem cells (1) for the treatment of hematological neoplasms particularly in patients with LPD.
Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.
Liang, "Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene," Experimental and Therapeutic Medicine, vol.
Group 1 Group 2 Group 3 Number (patients) 20 20 20 Kellgren-Lawrence Gr 2 = 11 Gr 2 = 11 Gr 2 = 11 classification Gr 3 = 9 Gr 3 = 9 Gr 3 = 9 Gr 2-3 MC = 9 MC = 8 Intraoperative LC = 1 LC = 1 N/A location PF = 3 PF = 3 MUL=7 MUL = 8 ICRS classification III = 12, IV =8 III = 10, IV =10 N/A Size of lesion (cm) 2.5 x 2.7 2.5 x 2.6 N/A TABLE 3: Activated autologous peripheral blood stem cell collection counts (total nucleated cells (TNC), [CD34.sup.+] cells, and [CD105.sup.+] cells) and cell viability at different times of injection in all patients.
Quality control of bacterial contamination in autologous peripheral blood stem cells
Siew-Yoke Jee et al., "Articular cartilage regeneration with autologous peripheral blood stem cells
versus hyaluronic acid: a randomized controlled trial," Arthroscopy, vol.